History of Max Gerson and the Gerson Therapy

Overview
Early Life and Medical Training
The Migraine Diet
Skin Tuberculosis and the Sauerbruch–Herrmannsdorfer–Gerson Diet
Flight from Nazi Germany and Emigration to the United States
The Pivot to Cancer
The Pepper–Neely Hearings of 1946
Albert Schweitzer and the “Medical Genius” Quote
A Cancer Therapy: Results of Fifty Cases (1958)
After Gerson: Charlotte, the Institute, and the Tijuana Clinic
Key Research and Sources
Featured Videos

Overview

Max Gerson (1881–1959) was a German-trained internist who, over a roughly forty-year career, built a single nutritional and detoxification protocol he believed could treat conditions as different as migraines, skin tuberculosis, cardiovascular disease, kidney disease, and cancer. The protocol — what we now call the Gerson Therapy — was not invented in one moment. It was assembled gradually, beginning with a low-salt, plant-heavy diet for his own crippling migraines in his twenties, then expanded through hospital trials in interwar Germany, and finally codified in his 1958 book A Cancer Therapy: Results of Fifty Cases, published in New York the year before his death.

To understand why the therapy looks the way it does — thirteen freshly pressed juices a day, no salt, multiple coffee enemas, doses of Lugol’s iodine and thyroid extract — you have to follow the historical thread from the Munich migraine clinic through the Sauerbruch tuberculosis trials to the Manhattan office where he treated Albert Schweitzer’s wife. Each piece of the modern protocol corresponds to a specific clinical observation Gerson made along the way.

Early Life and Medical Training

Max Gerson was born on October 18, 1881, in Wongrowitz in the Prussian province of Posen (now Wagrowiec, Poland). He was the third of nine children in an Orthodox Jewish family. After completing his secondary education, he studied medicine at the universities of Breslau, Würzburg, Berlin, and Freiburg, the standard rotating pattern of the German medical-school system at the turn of the twentieth century. He earned his medical degree in 1909 and began postgraduate work in internal medicine and neurology.

From his student years he suffered debilitating, sometimes daily, migraines. The standard medical advice of the day — rest, ergotamine, opium — gave him no lasting relief. Gerson read widely outside the medical orthodoxy, including the dietary writings of the Swiss physician Maximilian Bircher-Benner (the inventor of muesli), and decided to experiment on himself with a strict plant-based, salt-restricted, nearly fat-free diet. The migraines stopped. This was the founding clinical observation of his entire career.

The Migraine Diet

By the early 1920s Gerson, then practicing in Bielefeld and later in Kassel, was recommending the same diet to his own migraine patients. He published the first formal description in the German medical literature in 1929 (Münchener Medizinische Wochenschrift) and reported that a substantial majority of patients with chronic migraines became symptom-free within weeks. The diet had three rules that would persist through every later version of his work: (1) no added salt, (2) almost no animal fat, and (3) heavy emphasis on fresh raw plant food, with juices as the most concentrated form of intake.

What Gerson did not know in 1929 was that he had stumbled onto a sodium-restriction protocol decades before the link between sodium intake, vasoconstriction, and vascular headache would be formally explored. Modern migraine prevention literature still considers low-sodium DASH-style diets a reasonable adjunct, particularly in salt-sensitive patients. The mechanism Gerson invoked — a generalized “sodium–potassium balance” in the cellular metabolism — was speculative, but the clinical observation was reproducible.

Skin Tuberculosis and the Sauerbruch–Herrmannsdorfer–Gerson Diet

The next leap came when one of Gerson’s migraine patients had been suffering simultaneously from lupus vulgaris, a chronic, disfiguring tuberculosis of the skin that in the pre-antibiotic era had no reliable cure. The patient’s skin lesions cleared on the migraine diet. Gerson, recognizing that this was the kind of result that would attract serious attention, contacted Ferdinand Sauerbruch, then the most prominent thoracic surgeon in Germany, who arranged a controlled hospital trial at his Munich clinic.

The Sauerbruch–Herrmannsdorfer–Gerson trial enrolled 450 patients with skin tuberculosis. The published result, in 1929, was that 446 of 450 healed. The diet was added to the German tuberculosis-treatment guidelines and was used clinically until isoniazid and the BCG-vaccination programs of the 1950s rendered it obsolete. The Sauerbruch trial is the single largest body of clinical evidence Gerson ever generated, and unlike his later cancer claims it was published in mainstream German journals and reproduced in subsequent series.

Flight from Nazi Germany and Emigration to the United States

As a Jewish physician, Gerson was forced out of his German practice in 1933 after the National Socialist regime stripped Jewish doctors of state-insurance billing rights. He moved first to Vienna, then to Paris, and finally arrived in New York in 1936. He was licensed to practice medicine in New York State in 1938 after passing the medical-board examinations in English — a substantial accomplishment in his fifties.

From 1938 until his death in 1959 he ran a private practice in Manhattan and a sanitarium first in Nanuet and later at Gotham Hospital, treating patients with a wide range of chronic conditions. The patient population shifted gradually toward cancer, partly because oncology in the 1940s and 1950s offered very limited curative options for advanced solid tumors and partly because patients who failed conventional therapy heard of Gerson by word of mouth.

The Pivot to Cancer

Gerson did not start with cancer. Throughout the late 1930s and 1940s he treated tuberculosis, cardiovascular disease, kidney disease, arthritis, and a long list of other chronic conditions with versions of his diet. He came to cancer through patients who happened to have it as a co-morbidity. By the mid-1940s he was modifying the diet specifically for malignancy: more frequent juices, the addition of coffee enemas (taken from the surgical and palliative-care literature of the day, where coffee enemas had appeared in the Merck Manual since 1899 for analgesia and bowel evacuation), Lugol’s iodine, and crude liver injections combined with raw calf-liver juice.

His theoretical framework was that cancer was a systemic metabolic disease — a failure of cellular sodium–potassium balance and of the liver’s detoxification capacity — rather than a primarily local disease of mutated tumor cells. This view was idiosyncratic in 1945 and is even more so in light of the modern molecular understanding of carcinogenesis, but variants of the “cancer as metabolic disease” hypothesis have continued to surface in the literature, most notably in the work of Otto Warburg and more recently of Thomas Seyfried.

The Pepper–Neely Hearings of 1946

In July 1946, Senator Claude Pepper of Florida convened hearings on a proposed federal cancer-research appropriation bill. Gerson was invited to testify and presented five cancer patients before the Senate subcommittee, with their X-rays and pathology reports. The hearings were broadcast on national radio. The Pepper–Neely bill, which would have funded a $100 million federal investigation into cancer therapies including dietary approaches, ultimately failed by a single vote in committee.

The episode is sometimes described in alternative-medicine literature as a turning point at which mainstream American medicine refused to investigate Gerson’s methods. The historical record is more complicated: the American Medical Association did review his case reports and concluded they were inadequately documented, and the National Cancer Institute later examined fifty patient charts Gerson submitted and found that the documentation did not meet the institute’s standards for case-series review. Both findings have been disputed by Gerson Institute historians.

Albert Schweitzer and the “Medical Genius” Quote

One of the most-quoted endorsements of Gerson came from Albert Schweitzer, the Nobel-Peace-Prize-winning physician and theologian. Schweitzer wrote, after Gerson treated his wife Helene for what was reported to be advanced pulmonary tuberculosis, that Gerson was “one of the most eminent geniuses in medical history.” Schweitzer’s wife survived another thirty years. Schweitzer himself was treated by Gerson for his own type II diabetes, which according to Schweitzer’s own letters required progressively less insulin on the diet.

The Schweitzer endorsement is genuine and verifiable in Schweitzer’s correspondence; it is used heavily in Gerson Institute materials. What it does not establish is efficacy in cancer. Schweitzer was treated for diabetes and his wife for tuberculosis — conditions where Gerson had decades of clinical experience — not for malignancy.

A Cancer Therapy: Results of Fifty Cases (1958)

In 1958, the year before his death, Gerson published his summary work, A Cancer Therapy: Results of Fifty Cases and the Cure of Advanced Cancer by Diet Therapy. The book describes the diet, the supplements, the enemas, the schedule, the “healing reactions” (flares of symptoms which Gerson interpreted as detoxification crises), and presents fifty patient case histories, mostly with imaging and pathology reports. The book is still in print and is the foundational document of the modern Gerson Therapy. It is freely available in full at the Gerson Institute’s website.

The methodological problems with the case series are the ones that recur in alternative-medicine literature generally: no controls, selection of favorable cases, incomplete follow-up, and reliance on outside-clinic biopsy reports of variable quality. These problems do not refute the case histories — some patients clearly did experience long-term remission of biopsy-confirmed cancer — but they make it impossible to estimate the response rate one would have seen in an unselected consecutive cohort.

After Gerson: Charlotte, the Institute, and the Tijuana Clinic

Max Gerson died of pneumonia in 1959 at age seventy-seven. His daughter Charlotte Gerson (1922–2019) carried the work forward, founding the Gerson Institute in Bonita, California in 1977. Because the FDA does not permit American clinics to administer the full protocol (the regulatory issues center on Lugol’s iodine doses and the use of crude liver injection in the original protocol), the Gerson Institute partners with licensed Mexican clinics, primarily in Tijuana, where the inpatient phase of the therapy can be administered legally. Patients typically stay two to three weeks, then continue at home for eighteen to twenty-four months.

The protocol has been refined since 1959. Crude liver injections were dropped after a salmonella outbreak in the early 1980s. Raw calf-liver juice was discontinued in the 1990s after concerns about microbial contamination. Pancreatic enzyme dosing has been reduced. The current Gerson Institute protocol — the version that practitioners around the world now follow — is described in detail in Charlotte Gerson and Beata Bishop’s 2007 book Healing the Gerson Way, which is the closest thing to a current authoritative manual.

Key Research and Sources

Gerson M (1958). A Cancer Therapy: Results of Fifty Cases. Whittier Books. Reprinted by Gerson Institute, 2002.
Gerson M (1978). “The cure of advanced cancer by diet therapy: a summary of 30 years of clinical experimentation.” Physiological Chemistry and Physics 10(5):449–464. PMID: 751079
Sauerbruch F, Herrmannsdorfer A, Gerson M (1929). Reports on the dietary treatment of skin tuberculosis. Münchener Medizinische Wochenschrift 76:113.
Hildenbrand GL et al. (1995). “Five-year survival rates of melanoma patients treated by diet therapy after the manner of Gerson: a retrospective review.” Alternative Therapies in Health and Medicine. PMID: 9359807
Gerson Institute. Historical archives and biographical timeline. gerson.org
U.S. Senate, 79th Congress. Hearings on S.1875 (the Pepper–Neely Anticancer Bill), July 1946. Congressional Record.
PubMed search: “Gerson therapy” on PubMed
PubMed search: “Max Gerson lupus vulgaris”